U.S. markets closed
  • S&P Futures

    3,901.50
    -2.25 (-0.06%)
     
  • Dow Futures

    31,419.00
    -2.00 (-0.01%)
     
  • Nasdaq Futures

    12,026.50
    -14.00 (-0.12%)
     
  • Russell 2000 Futures

    1,770.50
    +0.70 (+0.04%)
     
  • Crude Oil

    110.69
    +1.12 (+1.02%)
     
  • Gold

    1,826.70
    +1.90 (+0.10%)
     
  • Silver

    21.12
    -0.04 (-0.20%)
     
  • EUR/USD

    1.0584
    -0.0002 (-0.02%)
     
  • 10-Yr Bond

    3.1940
    +0.0690 (+2.21%)
     
  • Vix

    26.95
    -0.28 (-1.03%)
     
  • GBP/USD

    1.2276
    +0.0006 (+0.05%)
     
  • USD/JPY

    135.2860
    -0.1600 (-0.12%)
     
  • BTC-USD

    20,706.99
    -434.60 (-2.06%)
     
  • CMC Crypto 200

    449.66
    -12.13 (-2.63%)
     
  • FTSE 100

    7,258.32
    +49.51 (+0.69%)
     
  • Nikkei 225

    26,830.69
    -40.58 (-0.15%)
     

BiomX Presenting at Three Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

2022 Aegis Virtual Conference on February 24, 2022

Chardan 4th Annual Microbiome Medicines Summit on March 1, 2022

Oppenheimer & Co. 32nd Annual Virtual Healthcare Conference on March 17, 2022

NESS ZIONA, Israel, February 24, 2022--(BUSINESS WIRE)--BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that Jonathan Solomon, Chief Executive Officer of BiomX, will present at the 2022 Aegis Virtual Conference on February 24, 2022, the Chardan 4th Annual Microbiome Medicines Summit on March 1, 2022 and the Oppenheimer & Co. 32nd Annual Healthcare Conference on March 17, 2022.

2022 Aegis Virtual Conference – February 23-25, 2022

Date & Time:

Thursday, March 24, 2:30 PM EST

Presenter:

Jonathan Solomon

Conference registration:

Link

Chardan 4th Annual Microbiome Medicines Summit – March 1, 2022

Date & Time:

Tuesday, March 1, 8:30 AM EST

Presenter:

Conference registration:

Jonathon Solomon

Link

Oppenheimer & Co. 32nd Annual Healthcare Conference – March 15-17, 2022

Date & Time:

Thursday, March 17, 2:00 PM EST

Presenter:

Jonathan Solomon

Conference registration:

Link

Live webcasts of presentations will also be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX Inc.

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.BiomX.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005117/en/

Contacts

BiomX Contacts

Investor Relations:
LifeSci Advisors, LLC
John Mullaly
(617)-698-9253
jmullaly@lifesciadvisors.com

BiomX, Inc.
Anat Primovich
Corporate Project Manager
+972 (50) 697-7228
anatp@biomx.com